Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of U101 for Bladder Pain and/or Urgency

ClinicalTrials.gov ID: NCT00256542

Public ClinicalTrials.gov record NCT00256542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 2:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether intravesical U101 (alkalinized lidocaine-heparin) treatment reduces the symptoms of pelvic pain and/or urgency of bladder origin.

Study identification

NCT ID
NCT00256542
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Urigen
Industry
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Not listed
Completion
Sep 2006 (Type not available)
Last update posted
Sep 29, 2006

2006

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
UCSD Medical Center San Diego California 92103 —
Georgia Urology Cartersville Georgia 30120 —
St. Mary's Good Samaritan Centralia Illinois 62801 —
The Urogynecology Center Overland Park Kansas 66215 —
Mid-Michigan Health Centers Jackson Michigan 49201 —
Central Park Urology New York New York 10019 —
The Urology Center Greensboro North Carolina 27403 —
Urologic Specialists of Oklahoma, Inc. Tulsa Oklahoma 74146 —
Whitmore Urology Office Philadelphia Pennsylvania 19146 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00256542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2006 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00256542 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →